IP Library Patent Application 17998215
Patent Application
App. No. 17/998,215

TDD TRACKING APPROACHES FOR INSULIN DELIVERY SYSTEMS, METHODS, AND DEVICES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/998,215
Abstract

A system includes a controller that is in communication with a medication delivery device and that includes control logic. The control logic is operative to calculate a first filtered total daily dose (TDD) during an initial tracking phase based, at least in part, on a first set of insulin delivery doses and subject to a first set of rate limits. The control logic is also operative to calculate a second filtered TDD during a steady state tracking phase based, at least in part, on a second set of insulin delivery doses and subject to a second set of rate limits.

Claims (46)

1 . A system to control glucose in a patient, the system comprising:

a controller configured to communicate with a medication delivery device and including control logic operative to:

calculate a first filtered total daily dose (TDD) during an initial tracking phase based, at least in part, on a first set of insulin delivery doses and subject to a first set of rate limits, and

calculate a second filtered TDD during a steady state tracking phase based, at least in part, on a second set of insulin delivery doses and subject to a second set of rate limits.

2 . The system of claim 1 , wherein the control logic is further operative to:

set a first system gain based, at least in part, on the first filtered TDD, and

set of second system gain based, at least in part on the second filtered TDD.

3 . The system of claim 2 , wherein the control logic is further operative to:

calculate a first set of basal doses based, at least in part, on the first system gain, and

calculate a second set of basal doses based, at least in part on the second system gain.

4 . The system of claim 1 , wherein the first set of rate limits includes a first upper limit and a first lower limit, wherein the second set of rate limits includes a second upper limit and a second lower limit, wherein the first set of rate limits permit greater TDD rate changes than the second set of rate limits.

5 . The system of claim 4 , wherein the second lower limit permits a greater absolute rate change than the second upper limit.

6 . The system of claim 1 , wherein the first set of insulin delivery doses are based on fewer TDD measurements than the second set of insulin delivery doses.

7 . The system of claim 1 , wherein the control logic is operative to transition to the steady state tracking phase after applying the initiation tracking phase for a period of time or in response to a pre-determined number of valid actual TDD measurements.

8 . The system of claim 1 , wherein the control logic is further operative to:

calculate an estimated TDD at start-up of an initialization phase based, at least in part, on a total daily basal (TDB) level.

9 . The system of claim 8 , wherein the estimated TDD is a pre-determined ratio of TDB.

10 . The system of claim 1 , wherein the first filtered TDD and the second filtered TDD are limited to a pre-determined ratio of total daily basal.

11 . The system of claim 1 , wherein the control logic is operative to:

calculate the first filtered TDD during the initial tracking phase once per day, and

calculate the second filtered TDD during the steady state tracking phase once per day.

12 . The system of claim 1 , wherein the control logic is operative to:

calculate the first filtered TDD by processing the first set of insulin delivery doses with an infinite impulse response (IIR) filter, and

calculate the second filtered TDD by processing the second set of insulin delivery doses with the IIR filter.

13 . The system of claim 1 , further comprising:

the medication delivery device configured to deliver insulin to the patient based, at least in part, to the first filtered TDD during the initiation tracking phase and the second filtered TDD during the steady state tracking phase.

14 . The system of claim 13 , further comprising the insulin contained in the medication delivery device.

15 . The system of claim 1 , further comprising:

a glucose measurement device in communication with the controller and configured to measure the glucose level.

16 . A method comprising:

calculating, by a controller applying a digital filter, a first filtered total daily dose (TDD) during an initial tracking phase based, at least in part, on a first set of insulin delivery doses and subject to a first set of rate limits;

calculating, by the controller, a first set of basal rates based, at least in part, on the first filtered TDD;

calculating, by the controller applying the digital filter, a second filtered TDD during a steady state tracking phase based, at least in part, on a second set of insulin delivery doses and subject to a second set of rate limits; and

calculating, by the controller, a second set of basal rates based, at least in part, on the second filtered TDD.

17 . The method of claim 16 , further comprising:

delivering, by a medication delivery device, amounts of insulin responsive to the first set of basal rates; and

delivering, by the medication delivery device, amounts of insulin responsive to the second set of basal rates.

18 . The method of claim 16 , further comprising:

setting a first system gain based, at least in part, on the first filtered TDD, and

setting of second system gain based, at least in part on the second filtered TDD, wherein the first set of basal rates based, at least in part, on the first system gain, wherein the second set of basal rates based, at least in part, on the second system gain.

19 . The method of claim 16 , further comprising:

calculating an estimated TDD during an initialization phase based, at least in part, on a total daily basal level.

20 . The method of claim 16 , wherein the first filtered TDD and the second filtered TDD are limited to a pre-determined ratio of a total daily basal level.

21 . A non-transitory computer-readable medium including instructions that, when executed, cause a hardware processor to:

calculate a first filtered total daily dose (TDD) during an initial tracking phase based, at least in part, on a first set of insulin delivery doses and subject to a first set of rate limits; and

calculate a second filtered TDD during a steady state tracking phase based, at least in part, on a second set of insulin delivery doses and subject to a second set of rate limits.

Assignments (3)
CHANGE OF NAME Recorded Mar 18, 2026
From: YPSOMED DIABETES CARE AG
To: MYLIFE DIABETES CARE AG
Reel/Frame 074111/0121 →
CONFIRMATORY ASSIGNMENT Recorded Aug 17, 2023
From: ELI LILLY AND COMPANY
To: YPSOMED AG
Reel/Frame 064623/0041 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2022
From: BARTEE, AMY KATHLEEN; HAIDAR, AHMAD MOHAMAD; JONES, RICHARD E, JR.
To: ELI LILLY AND COMPANY
Reel/Frame 061695/0111 →